-+ 0.00%
-+ 0.00%
-+ 0.00%

LifeMD Q1 FY26 adjusted EBITDA loss widens to $4.5 million; revenue falls 1% to $50.2 million

PUBT·05/06/2026 20:25:11
Listen to the news
LifeMD Q1 FY26 adjusted EBITDA loss widens to $4.5 million; revenue falls 1% to $50.2 million
  • LifeMD posted Q1 revenue of USD 50.2 million, down 1%, while net loss attributable to common stockholders widened to USD 9.6 million, or USD 0.20 per share.
  • Gross margin expanded 4.2 percentage points to 88%, reflecting favorable revenue mix and lower fulfillment costs.
  • Selling and marketing expense rose 34% to USD 29.9 million as the company front-loaded patient acquisition spending; active subscribers increased 26% to 365,004.
  • LifeMD ended quarter with USD 34.5 million cash and no debt, affirming full-year revenue outlook of USD 220 million to USD 230 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeMD Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605061605PRIMZONEFULLFEED9714681) on May 06, 2026, and is solely responsible for the information contained therein.